Seems to me that significant things have changed in the detection protocols for the heart issues related to Covid 19.
Possibly as a result from such new information as this from the American Heart Association in August:
"Initially thought to be an infection causing disease of the lungs, inflammation of the vascular system and injury to the heart appear to be common features of this novel coronavirus, occurring in 20% to 30% of hospitalized patients and contributing to 40% of deaths.
[1] The risk of death from COVID-19-related heart damage appears to be as or more important than other well-described risk factors for COVID-related mortality, such as age, diabetes mellitus, chronic pulmonary disease or prior history of cardiovascular disease.2,4
Much remains to be learned about COVID-19 infection and the heart. Although we think of the lungs being the primary target, there are frequent biomarker elevations noted in infected patients that are usually associated with acute heart injury. Moreover, several devastating complications of COVID-19 are cardiac in nature and may result in lingering cardiac dysfunction beyond the course of the viral illness itself,” said Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, president of the American Heart Association, the world’s leading voluntary organization focused on heart and brain health and research, and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center. “The need for additional research remains critical. We simply don’t have enough information to provide the definitive answers people want and need.”
There is so much new information and hype related to Covid 19. As recent as August the use of certain drugs were touted by President Trump and other political personages. Critics delivered their concerns about research detailing promising COVID-19 cures, including
remdesivir,
Moderna, and
Oxford. But the hydroxychloroquine and heart drug studies are the first to have been withdrawn. It seems that increased heart problems may have been attributed to hydroxychloroquine. And the details of the study were flawed.
At least the awareness of heart problems and instituting faster detection protocols and follow up procedures uniformly across the Big Ten universities have been instituted.
Questions were raised by officials representing various universities in the Big Ten. Those questions have been answered.